Methods of synthesizing a prostacyclin analog
Abstract
or a pharmaceutically acceptable salt thereof, wherein R10 is a linear or branched C1-6 alkyl. The processes of the present invention comprise steps that generate improved yields and fewer byproducts than traditional methods. The processes of the present invention employ reagents (e.g., the oxidizing reagent) that are less toxic that those used in the traditional methods (e.g., oxalyl chloride). Many of the processes of the present invention generate intermediates with improved e.e. and chemical purity; thereby eliminating the need of additional chromatography steps. And, the processes of the present invention are scalable to generate commercial quantities of the final compound.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A compound of Formula 13
wherein R 1 is C 1-6 alkyl and each R 2 is independently selected from C 1-6 alkyl or phenyl.
2 . A method of generating a compound of Formula 13
wherein R 1 is C 1-6 alkyl and each R 2 is independently selected from C 1-6 alkyl or phenyl, comprising
x) reacting a compound of Formula 12 with (R)-1-methyl-3,3-diphenylhexahydropyrrolo[1,2-c][1,3,2]oxazaborole in the presence of an organic solvent comprising THF and toluene to generate a compound of Formula 13
wherein the compound of Formula 13 has a chemical purity of about 97% or greater and a d.e. of about 97% or greater.
3 . A method of generating a compound of Formula I
or a pharmaceutically acceptable salt thereof, comprising the steps of:
xv) reacting a compound of Formula 21a with n-butyllithium in the presence of an organic solvent and a transition metal catalyst to generate a compound of Formula 22a
wherein R 1 is C 1-6 alkyl; and
xvi) converting the compound of Formula 22a to the compound of Formula I.
4 . The method of claim 3 , wherein the transition metal catalyst comprises a compound or complex either of which comprises copper having a +1 oxidation state.
5 . The method of claim 4 , wherein the transition metal catalyst comprises CuI.
6 . The method of claim 3 , further comprising the steps of:
xvii) reacting a compound of Formula 19a with triisopropylbenzenesulfonyl chloride under basic conditions to generate a compound of Formula 20a; and
xviii) reacting the compound of Formula 20a with methanol under basic conditions to generate the compound of Formula 21a.
7 . The method of claim 6 , further comprising the steps of
xix) reacting a compound of Formula 16a with a reducing agent to generate a compound of Formula 17a;
xx) reacting the compound of Formula 17a with TBDPSCl under basic conditions to generate a compound of Formula 18a; and
xxi) selectively deprotecting the compound of Formula 18a to generate the compound of Formula 19a.
8 . The method of claim 7 , further comprising the steps of:
xii) hydrogenating a compound of Formula 15a
in the presence of an alcohol, optionally substituted THF, or any combination thereof to generate the compound of Formula 16a.
9 . The method of claim 8 , further comprising the steps of:
x) reacting a compound of Formula 12a with a reducing agent to generate a compound of Formula 13a; and
xiv) converting the compound of Formula 13a to the compound of Formula 15a.
10 . The method of claim 9 , further comprising the step of:
v) reacting a compound of Formula 11a
with an oxidizing agent to generate the compound of Formula 12a, wherein the oxidizing agent comprises MnO 2 .
11 . The method of claim 9 , further comprising the steps of:
i) reacting a compound of Formula 9 with an oxidizing agent to generate a compound of Formula 10; and
ii) reacting the compound of Formula 10 with a compound of Formula 5a in the presence of a base and an organic solvent to generate a compound of Formula 11a
12 . The method of claim 11 , further comprising the steps of:
iv) refluxing the compound of Formula 1a in the presence of methanol to generate a compound of Formula 1 having an e.e. of greater than about 98%;
v) reacting the compound of Formula 1 with TBSCl under basic conditions to generate the compound of Formula 2a;
vi) reacting the compound of Formula 2a with 1-TMS-1-propyne to generate the compound of Formula 3a; and
vii) converting the compound of Formula 3a to the compound of Formula 5a.
13 . The method of claim 12 , further comprising the steps of:
xxii) reacting a compound of Formula 7a with a 3-haloprop-1-ene in the presence of a base and an organic solvent to generate a compound of Formula 8a; and
xxiii) deprotecting the compound of Formula 8a to generate the compound of Formula 9.
14 . A method of generating a compound of Formula I
or a pharmaceutically acceptable salt thereof, comprising the steps of:
i) reacting a compound of Formula 9 with an oxidizing agent to generate a compound of Formula 10;
ii) reacting the compound of Formula 10 with a compound of Formula 5a in the presence of a base and an organic solvent to generate a compound of Formula 11a;
iv) refluxing the compound of Formula 1a in the presence of methanol to generate a compound of Formula 1 having an e.e. of greater than about 98%;
v) reacting the compound of Formula 1 with TBSCl under basic conditions to generate the compound of Formula 2a;
vi) reacting the compound of Formula 2a with 1-TMS-1-propyne to generate the compound of Formula 3a;
vii) converting the compound of Formula 3a to the compound of Formula 5a;
viii) reacting a compound of Formula 11a with an oxidizing agent to generate the compound of Formula 12a, wherein the oxidizing agent comprises MnO 2 ;
x) reacting a compound of Formula 12a with a reducing agent to generate a compound of Formula 13a;
xiv) converting the compound of Formula 13a to the compound of Formula 15a;
xii) hydrogenating a compound of Formula 15a in the presence of methanol, ethanol, THF, 2-methyl-THF, or any combination thereof to generate the compound of Formula 16a;
xix) reacting a compound of Formula 16a with a reducing agent to generate a compound of Formula 17a;
xx) reacting the compound of Formula 17a with TDPSCl under basic conditions to generate a compound of Formula 18a;
xxi) selectively deprotecting the compound of Formula 18a to generate the compound of Formula 19a;
xvii) reacting a compound of Formula 19a with triisopropylbenzenesulfonyl chloride under basic conditions to generate a compound of Formula 20a;
xviii) reacting the compound of Formula 20a with methanol under basic conditions to generate the compound of Formula 21a;
xv) reacting a compound of Formula 21a with n-butyllithium in the presence of an organic solvent and a transition metal catalyst to generate a compound of Formula 22a; and
xvi) converting the compound of Formula 22a to the compound of Formula I.
15 . The method of claim 14 , further comprising the step of:
xxiv) reacting the compound of Formula I with diethanolamine in the presence of an organic solvent to generate the diethanolamine salt of the compound of Formula I.
16 . A compound of Formula 1a
17 . A method of purifying a compound of Formula 1 comprising:
xxx) reacting a compound of Formula 1 with a derivatizing reagent to generate a precipitate that is substantially insoluble in dichloromethane or mixtures thereof;
xxxi) collecting the precipitate and refluxing the precipitate in a solvent comprising an alcohol to generate the compound of Formula 1 having a chemical purity of about 98% or greater and an e.e. of about 98% or greater;
wherein the method excludes the use of any column chromatography.
18 . The method of claim 17 , wherein the derivatizing reagent comprises 3,5-dinitrobenzoyl chloride and the alcohol comprises methanol.
19 . A method of purifying a compound of Formula 9 comprising:
xl) reacting a compound of Formula 9, wherein R 1 is C 1-6 alkyl, with 3,5-dinitrobenzoyl chloride to generate a precipitate comprising a compound of Formula 9A; and
xli) collecting the precipitate and treating the precipitate with a base in the presence of an alcohol to generate the compound of Formula 9 having a chemical purity of about 95% or greater;
wherein the method excludes the use of any column chromatography.
20 . The method of claim 19 , further comprising the step:
xlii) recrystallizing the precipitate of step xli).
21 . A compound of Formula 9a
wherein R 1 is C 1-6 alkyl.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.